Floatz logo

Inulin

Dysbiosis

Emory Universityother_biologicalPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Dysbiosis cohort.

Asset / SponsorPhaseRating
VITAMIN D
Emory University
Phase 4BB
Olea europaea oil
Mucosa Innovations, S.L.
N/AD
Trimethylglycine
Mucosa Innovations, S.L.
N/AD
ALLERGENIC EXTRACT- APPLE MALUS SP
University of Guelph
N/AD
Xylitol
Mucosa Innovations, S.L.
N/AD

Same molecule, other indications

Inulin is also rated in:

cystic fibrosisDormant
B
Indicative ·
62 / 100
View asset →
Obesity, AbdominalDormant
B
Indicative ·
57 / 100
View asset →
Antibiotic Resistant InfectionDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →